Cloning and functional characterization of a novel long non-coding RNA gene associated with hepatocellular Carcinoma

Progress in Biochemistry and Biophysics

Volumn 41, Issue 2, 2014, Pages 153-162

  Tang, Ke ^a   Wei, Fang ^a   Bo, Hao ^a   Huang, Hong Bin ^a,c   Zhang, Wen Ling ^a   Gong, Zhao Jian ^a   Li, Xia Yu ^b   Song, Ya Li ^a   Liao, Qian Jin ^a   Peng, Shu Ping ^a   Xiang, Juan Juan ^a   Zhou, Ming ^a   Ma, Jian ^a   Li, Xiao Ling ^a   Xiong, Wei ^a,b   Li, Yong ^d   Zeng, Zhao Yang ^a,b   Li, Gui Yuan ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^c NATIONAL UNIVERSITY OF DEFENSE TECHNOLOGY   (China)

^d University of Louisville School of Medicine   (United States)

Author keywords

Bioinformatics; Chromosome 1 lql3.1; Gene cloning; Hepatocellular carcinoma; Long non coding RNA

Indexed keywords

EID: 84903146757     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2012.00613     Document Type: Article

References (33)

1. Qing T, Yu Y, Du T T, et al. mRNA enrichment protocols determine the quantification characteristics of external RNA spike-in controls in RNA-Seq studies. Sci China Life Sci, 2013,56(2): 134-142
2. Gong Z, Zhang S, Zhang W, et al. Long non-coding RNAs in cancer. Sci China Life Sci, 2012,55(12): 1120-1124
3. Ponting C P, Oliver P L, Reik W. Evolution and functions of long noncoding RNAs. Cell, 2009,136(4): 629-641
4. Zhang W, Huang C, Gong Z, et al. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol, 2013, 44(5): 545-554 (DOI: 10.1007/sll427-013-4577y)
5. He S, Liu C, Skogerbo G, et al. NONCODE v2.0: decoding the non-coding. Nucleic Acids Res, 2008, 36(Database issue): D170- 172
6. Gong Z J, Huang H B, Xu K, et al. Prog Biochem Biophys, 2012, 39(12): 1133-1144
7. Zeng Z Y, Huang H B, Huang L L, et al. Expression profiles and regulation network of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinoma. Sci China Life Sci, 2014,57 (DOI:10.1007/sl 1427-013-4577y)
8. Wilusz J E, Sunwoo H, Spector D L. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 2009,23(13): 1494-1504
9. Tsai M C, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 2010, 329(5992): 689-693
10. Gupta R A, Shah N, Wang K C, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 2010,464(7291): 1071-1076
11. He S, Su H, Liu C, et al. MicroRNA-encoding long non-coding RNAs. BMC Genomics, 2008,9: 236
12. Li L, Feng T, Lian Y, et al. Role of human noncoding RNAs in the control of tumorigenesis. Proc Natl Acad Sci USA, 2009,106(31): 12956-12961
13. Gutschner T, Diederichs S. The Hallmarks of Cancer a long non-coding RNA point of view. RNA Biol, 2012,9(6): 1076-1087
14. Liao Q, Xiao H, Bu D, et al. ncFANs: a web server for functional annotation of long non-coding RNAs. Nucleic Acids Res, 2011, 39(Web Server issue): Wl 18-124
15. Guo X, Gao L, Liao Q, et al. Long non-coding RNAs function annotation: a global prediction method based on bi-colored networks. Nucleic Acids Res, 2013,42(2): e35
16. Li A, Wei G, Wang Y, et al. Identification of intermediate-size non-coding RNAs involved in the UV-induced DNA damage response in C. elegans. PLoS One, 2012,7(11): e48066
17. Pang K C, Frith M C, Mattick J S. Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet, 2006,22(1): 1-5 (Pubitemid 43011990)
18. Yang Z, Zhou L, Wu L M, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol, 2011, 18(5): 1243-1250
19. Yuan S X, Yang F, Yang Y, et al. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology, 2012,56(6): 2231-2241
20. Zhu Z, Gao X, He Y, et al. An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res, 2012,72(23): 6163-6172
21. Yang F, Zhang L, Huo X S, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology, 2011, 54(5): 1679-1689
22. Huang J F, Guo Y J, Zhao C X, et al. HBx-related lncRNA Dreh inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimen tin. Hepatology, 2013, 57(5): 1882-1892
23. Ying J, Shan L, Li J, et al. Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies llql3 amplification oncogenes associated with nodal metastasis. PLoS One, 2012, 7(6): e39797
24. Che Y, Ye F, Xu R, et al. Co-expression of XIAP and cyclin Dl complex correlates with a poor prognosis in patients with hepatocellular carcinoma. Am J Pathol, 2012,180(5): 1798-1807
25. Yang Y, Liao Q, Wei F, et al. LPLUNCl inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One, 2013,8(5): e62869
26. Xavier F C, Rodini C O, Paiva K B, et al. ORAOVl is amplified in oral squamous cell carcinoma. J Oral Pathol Med, 2011, 41(1): 54-60
27. Takita J, Chen Y, Okubo J, et al. Aberrations of NEGRI on lp31 and MYEOV on llql3 in neuroblastoma. Cancer Sci, 2011, 102(9): 1645-1650
28. Sawey E T, Chanrion M, Cai C, et al. Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell, 2011, 19(3): 347-358
29. Arao T, Ueshima K, Matsumoto K, et al. FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma. Hepatology, 2013,57(4): 1407-1415
30. Yin P, Zhao C, Li Z, et al. Spi is involved in regulation of cystathionine gamma-lyase gene expression and biological function by PI3K/Akt pathway in human hepatocellular carcinoma cell lines. Cell Signal, 2012,24(6): 1229-1240
31. Yu J H, Zhu B M, Riedlinger G, et al. The liver-specific tumor suppressor STAT5 controls expression of the reactive oxygen species-generating enzyme NOX4 and the proapoptotic proteins PUMA and BUM in mice. Hepatology, 2012,56(6): 2375-2386
32. Liao Q, Zeng Z, Guo X, et al. LPLUNCl suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene, 2013(DOI: 10.1038/onc.2013.161)
33. Zwang Y, Oren M, Yarden Y. Consistency test of the cell cycle: roles forp53 and EGRI. Cancer Res, 2012,72(5): 1051-1054